A deal, Leicht and Ball think, is therefore urgent. They propose it involves federal regulation on frontier AI, alongside ...

Prioritization of refractory rheumatoid arthritis (RA) as lead indication for AlloNK® development FDA Fast Track Designation received for AlloNK in refractory RA, representing the first drug candidate ...

Apple launches its new M5 iPad Pro, also debuts with Apple's new silicon with C1X and N1 chips, faster charging, faster AI performance, and more.

Prioritization of refractory rheumatoid arthritis (RA) as lead indication for AlloNK® development FDA Fast Track Designation received for AlloNK ...

RetinalGenix Technologies Inc. [OTCQB: RTGN] ("RetinalGenix" or the "Company"), a company developing ultra-high-resolution retinal imaging technology ...

For now, let's examine the typical domains powering the current generation of software-defined vehicles. This minicomputer ...

In the past few weeks, several major stories have emerged that are seismically shaking up the cellular industry, with impacts ...

Findings complement previously announced results in triple-negative breast cancer (TNBC) and prostate cancer models, highlighting Telomir-1’s consistent impact on cancer cell survival pathways. MIAMI, ...

Bell is preparing to launch its direct-to-cell satellite service, promising full mobile connectivity for Canadians in remote ...

An app that let Pixel phones use VoLTE and VoWiFi in any region has been blocked with the latest Android update. Here's what to know.

PDA-002 is a mesenchymal stromal-like cell therapy product derived from the postpartum placenta. These cells possess potent angiogenic, immunomodulatory, and tissue-repair properties, offering a novel ...